HUE045337T2 - Eljárás primer hiperaldoszteronizmus diagnosztizálására - Google Patents
Eljárás primer hiperaldoszteronizmus diagnosztizálásáraInfo
- Publication number
- HUE045337T2 HUE045337T2 HUE14789218A HUE14789218A HUE045337T2 HU E045337 T2 HUE045337 T2 HU E045337T2 HU E14789218 A HUE14789218 A HU E14789218A HU E14789218 A HUE14789218 A HU E14789218A HU E045337 T2 HUE045337 T2 HU E045337T2
- Authority
- HU
- Hungary
- Prior art keywords
- diagnosis
- primary hyperaldosteronism
- hyperaldosteronism
- primary
- Prior art date
Links
Classifications
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/74—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving hormones or other non-cytokine intercellular protein regulatory factors such as growth factors, including receptors to hormones and growth factors
- G01N33/743—Steroid hormones
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/16—Amides, e.g. hydroxamic acids
- A61K31/165—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
- A61K31/401—Proline; Derivatives thereof, e.g. captopril
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/4164—1,3-Diazoles
- A61K31/4178—1,3-Diazoles not condensed 1,3-diazoles and containing further heterocyclic rings, e.g. pilocarpine, nitrofurantoin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A61P5/38—Drugs for disorders of the endocrine system of the suprarenal hormones
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/483—Physical analysis of biological material
- G01N33/487—Physical analysis of biological material of liquid biological material
- G01N33/49—Blood
- G01N33/492—Determining multiple analytes
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/74—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving hormones or other non-cytokine intercellular protein regulatory factors such as growth factors, including receptors to hormones and growth factors
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
- G01N2333/435—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans
- G01N2333/705—Assays involving receptors, cell surface antigens or cell surface determinants
- G01N2333/72—Assays involving receptors, cell surface antigens or cell surface determinants for hormones
- G01N2333/723—Steroid/thyroid hormone superfamily, e.g. GR, EcR, androgen receptor, oestrogen receptor
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2410/00—Assays, e.g. immunoassays or enzyme assays, involving peptides of less than 20 animo acids
- G01N2410/02—Angiotensins; Related peptides
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2800/00—Detection or diagnosis of diseases
- G01N2800/04—Endocrine or metabolic disorders
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Chemical & Material Sciences (AREA)
- Biomedical Technology (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Molecular Biology (AREA)
- Hematology (AREA)
- Immunology (AREA)
- Urology & Nephrology (AREA)
- Physics & Mathematics (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Epidemiology (AREA)
- General Physics & Mathematics (AREA)
- Pathology (AREA)
- Food Science & Technology (AREA)
- Analytical Chemistry (AREA)
- Biochemistry (AREA)
- Endocrinology (AREA)
- Microbiology (AREA)
- Cell Biology (AREA)
- Biotechnology (AREA)
- Biophysics (AREA)
- Ecology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Diabetes (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Investigating Or Analysing Biological Materials (AREA)
- Steroid Compounds (AREA)
- Other Investigation Or Analysis Of Materials By Electrical Means (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
EP20130189386 EP2863228A1 (en) | 2013-10-18 | 2013-10-18 | Method for diagnosis of primary hyperaldosteronism |
EP14152763 | 2014-01-28 |
Publications (1)
Publication Number | Publication Date |
---|---|
HUE045337T2 true HUE045337T2 (hu) | 2019-12-30 |
Family
ID=51794861
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
HUE14789218A HUE045337T2 (hu) | 2013-10-18 | 2014-10-17 | Eljárás primer hiperaldoszteronizmus diagnosztizálására |
Country Status (13)
Country | Link |
---|---|
US (2) | US9829496B2 (hu) |
EP (1) | EP3058374B1 (hu) |
JP (1) | JP6397907B2 (hu) |
CN (1) | CN105683760A (hu) |
AU (1) | AU2014336122B2 (hu) |
BR (1) | BR112016007960B8 (hu) |
CA (1) | CA2926382C (hu) |
DK (1) | DK3058374T3 (hu) |
EA (1) | EA035289B1 (hu) |
ES (1) | ES2745099T3 (hu) |
HU (1) | HUE045337T2 (hu) |
PL (1) | PL3058374T3 (hu) |
WO (1) | WO2015055825A1 (hu) |
Families Citing this family (10)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US10559377B2 (en) | 2013-01-09 | 2020-02-11 | Biomed Concepts Inc. | Graphical user interface for identifying diagnostic and therapeutic options for medical conditions using electronic health records |
EA035289B1 (ru) * | 2013-10-18 | 2020-05-25 | Аттоквант Диагностикс Гмбх | Способ диагностики первичного гиперальдостеронизма |
WO2017127459A1 (en) * | 2016-01-19 | 2017-07-27 | Biomed Concepts Inc. | Method and system for identifying diagnostic and therapeutic options for medical conditions using electronic health records |
CA3041724C (en) * | 2016-11-17 | 2022-05-31 | Laboratory Corporation Of America Holdings | Methods and systems for measuring plasma renin activity |
CN106770824A (zh) * | 2016-12-21 | 2017-05-31 | 河南出入境检验检疫局检验检疫技术中心 | 利用高分辨质谱仪检测血浆中痕量醛固酮的方法 |
JP7067758B2 (ja) * | 2017-06-30 | 2022-05-16 | 国立大学法人 新潟大学 | 試料中のアンジオテンシンペプチドの量を測定するための方法及びアンジオテンシンペプチドの定量キット |
CN112037931B (zh) * | 2020-07-15 | 2023-10-20 | 新疆维吾尔自治区人民医院 | 在疑似原发性醛固酮增多症中应用的醛固酮增多预测体系 |
CN112014509A (zh) * | 2020-09-03 | 2020-12-01 | 复旦大学附属中山医院 | 同步测定样品中血管紧张素i和醛固酮的方法 |
CN113533552B (zh) * | 2021-06-02 | 2023-08-29 | 杭州凯莱谱精准医疗检测技术有限公司 | 液相色谱串联质谱检测肾素活性过程中对影响arr药物同步检测的方法 |
CN117554603B (zh) * | 2023-11-28 | 2024-05-10 | 中国医学科学院阜外医院 | 一种用于原发性醛固酮增多症初筛的标志物组合及其应用 |
Family Cites Families (11)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US3919407A (en) * | 1973-11-28 | 1975-11-11 | De Castro Aurora L Fernandez | Method for quantitative determination of renin activity in blood |
JPH022935A (ja) * | 1988-06-20 | 1990-01-08 | Tosoh Corp | アンジオテンシンの測定法 |
US5314804A (en) * | 1992-03-24 | 1994-05-24 | Serim Research Corporation | Test for Helicobacter pylori |
AU2002304965A1 (en) * | 2002-05-24 | 2003-12-12 | Zensun (Shanghai) Sci-Tech.Ltd | Neuregulin based methods and compositions for treating viral myocarditis and dilated cardiomyopathy |
WO2007109733A2 (en) * | 2006-03-21 | 2007-09-27 | The Johns Hopkins University | Diagnostic and prognostic markers and treatment strategies for multiple sclerosis |
EP2021324B1 (en) | 2006-05-29 | 2011-12-14 | NicOx S.A. | Nitrated heterocyclic compounds as endothelin receptor antagonist |
EP2129382A4 (en) | 2007-02-21 | 2011-01-19 | Univ Michigan | COMPOSITIONS AND METHODS FOR TRANQUILIZATION OF THE CARDIAC MUSCLE |
EP2225559B8 (en) * | 2007-12-28 | 2016-12-21 | F. Hoffmann-La Roche AG | Assessment of physiological conditions |
CN102586223A (zh) | 2012-03-08 | 2012-07-18 | 南京大学 | 一种基于mypt1基因敲除建立新型高血压小鼠模型的方法及其用途 |
WO2013134472A1 (en) * | 2012-03-08 | 2013-09-12 | Medtronic Ardian Luxembourg S.A.R.L. | Renal neuromodulation methods and systems for treatment of hyperaldosteronism |
EA035289B1 (ru) * | 2013-10-18 | 2020-05-25 | Аттоквант Диагностикс Гмбх | Способ диагностики первичного гиперальдостеронизма |
-
2014
- 2014-10-17 EA EA201690796A patent/EA035289B1/ru not_active IP Right Cessation
- 2014-10-17 EP EP14789218.6A patent/EP3058374B1/en active Active
- 2014-10-17 WO PCT/EP2014/072339 patent/WO2015055825A1/en active Application Filing
- 2014-10-17 ES ES14789218T patent/ES2745099T3/es active Active
- 2014-10-17 PL PL14789218T patent/PL3058374T3/pl unknown
- 2014-10-17 HU HUE14789218A patent/HUE045337T2/hu unknown
- 2014-10-17 DK DK14789218.6T patent/DK3058374T3/da active
- 2014-10-17 BR BR112016007960A patent/BR112016007960B8/pt active Search and Examination
- 2014-10-17 CA CA2926382A patent/CA2926382C/en active Active
- 2014-10-17 CN CN201480057185.8A patent/CN105683760A/zh active Pending
- 2014-10-17 US US15/030,339 patent/US9829496B2/en active Active
- 2014-10-17 JP JP2016524104A patent/JP6397907B2/ja active Active
- 2014-10-17 AU AU2014336122A patent/AU2014336122B2/en active Active
-
2017
- 2017-10-20 US US15/789,433 patent/US10295552B2/en active Active
Also Published As
Publication number | Publication date |
---|---|
AU2014336122B2 (en) | 2020-06-25 |
BR112016007960B1 (pt) | 2023-03-07 |
EP3058374A1 (en) | 2016-08-24 |
WO2015055825A1 (en) | 2015-04-23 |
NZ717888A (en) | 2022-03-25 |
US10295552B2 (en) | 2019-05-21 |
US9829496B2 (en) | 2017-11-28 |
EA201690796A1 (ru) | 2016-08-31 |
AU2014336122A1 (en) | 2016-04-07 |
US20180164330A1 (en) | 2018-06-14 |
BR112016007960A8 (pt) | 2020-03-17 |
EA035289B1 (ru) | 2020-05-25 |
CN105683760A (zh) | 2016-06-15 |
JP6397907B2 (ja) | 2018-09-26 |
JP2017500538A (ja) | 2017-01-05 |
ES2745099T3 (es) | 2020-02-27 |
PL3058374T3 (pl) | 2020-02-28 |
CA2926382C (en) | 2020-06-02 |
US20160266151A1 (en) | 2016-09-15 |
CA2926382A1 (en) | 2015-04-23 |
BR112016007960B8 (pt) | 2023-11-14 |
EP3058374B1 (en) | 2019-06-26 |
DK3058374T3 (da) | 2019-08-26 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
HRP20190600T1 (hr) | Postupak za neinvazivnu procjenu genetičkih varijacija | |
HK1220765A1 (zh) | 對樣本成像的方法 | |
SG11201510747RA (en) | Method for increasing expression of rna-encoded proteins | |
GB201401248D0 (en) | Method of manufacture | |
HUE045337T2 (hu) | Eljárás primer hiperaldoszteronizmus diagnosztizálására | |
HK1218014A1 (zh) | 用以間接判定參考間距的方法 | |
GB201412190D0 (en) | Method of optimization for an application | |
HK1214240A1 (zh) | 用於製備酰亞胺基二硫酰化合物的方法 | |
PL3071969T3 (pl) | Sposób analizy | |
GB201319875D0 (en) | Method of measuring isotape ratio | |
GB201305231D0 (en) | Method of Manufacture | |
IL241096A0 (en) | Treatment methods | |
HK1220969A1 (zh) | 用於合成伊立替康的方法 | |
PL3071958T3 (pl) | Sposób oceny potrzeb konserwacyjnych | |
GB201307256D0 (en) | Diagnostic method | |
HK1216419A1 (zh) | 合成方法 | |
GB201509658D0 (en) | Method of diagnosis | |
GB201221046D0 (en) | Method of diagnosis | |
GB201400510D0 (en) | Method of providing broadband connection | |
GB201311291D0 (en) | Method of manufacture | |
GB201300370D0 (en) | Method of calibrating asynchronies | |
GB201301262D0 (en) | Method of manufacture | |
SG10201701021XA (en) | Method of synthesis | |
GB201322778D0 (en) | Method of treatment | |
GB201314882D0 (en) | Method of treatment |